Renaissance Technologies’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.94M Sell
803,900
-239,600
-23% -$877K ﹤0.01% 1862
2025
Q1
$4.51M Sell
1,043,500
-30,000
-3% -$130K 0.01% 1499
2024
Q4
$3.44M Buy
1,073,500
+255,600
+31% +$818K 0.01% 1686
2024
Q3
$2.34M Buy
817,900
+22,200
+3% +$63.5K ﹤0.01% 1914
2024
Q2
$2.23M Sell
795,700
-11,400
-1% -$31.9K ﹤0.01% 1820
2024
Q1
$2.29M Sell
807,100
-50,625
-6% -$144K ﹤0.01% 1942
2023
Q4
$3.51M Buy
857,725
+173,631
+25% +$710K 0.01% 1573
2023
Q3
$2.18M Sell
684,094
-22,008
-3% -$70K ﹤0.01% 1813
2023
Q2
$2.34M Sell
706,102
-542,298
-43% -$1.8M ﹤0.01% 1893
2023
Q1
$2.66M Buy
1,248,400
+75,002
+6% +$160K ﹤0.01% 1853
2022
Q4
$3.16M Sell
1,173,398
-9,602
-0.8% -$25.8K ﹤0.01% 1784
2022
Q3
$3.83M Buy
1,183,000
+710,800
+151% +$2.3M 0.01% 1600
2022
Q2
$2.3M Buy
472,200
+126,400
+37% +$617K ﹤0.01% 2088
2022
Q1
$2.64M Buy
345,800
+220,200
+175% +$1.68M ﹤0.01% 2016
2021
Q4
$1.16M Sell
125,600
-244,000
-66% -$2.26M ﹤0.01% 2538
2021
Q3
$5.26M Sell
369,600
-339,600
-48% -$4.84M 0.01% 1436
2021
Q2
$11.8M Buy
709,200
+20,300
+3% +$337K 0.01% 1068
2021
Q1
$12.6M Buy
688,900
+42,600
+7% +$776K 0.02% 1039
2020
Q4
$4.87M Buy
646,300
+454,500
+237% +$3.42M 0.01% 1603
2020
Q3
$737K Buy
191,800
+57,300
+43% +$220K ﹤0.01% 2663
2020
Q2
$516K Buy
134,500
+66,900
+99% +$257K ﹤0.01% 2861
2020
Q1
$218K Buy
67,600
+32,300
+92% +$104K ﹤0.01% 3081
2019
Q4
$170K Buy
+35,300
New +$170K ﹤0.01% 3225